NFKB1 and gastric cancer: We found that 50μM-CM promoted proliferation (Figures 3D, E) and migration capacity (Figures 3F–H) in gastric cancer cells, and these effects were inhibited by the NF-κB signaling pathway inhibitor BAY11.7082.